Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs

Detalles Bibliográficos
Autores principales: Malapelle, Umberto, Pallante, Pierlorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439169/
https://www.ncbi.nlm.nih.gov/pubmed/28589123
http://dx.doi.org/10.3389/fmed.2017.00063
_version_ 1783237895524450304
author Malapelle, Umberto
Pallante, Pierlorenzo
author_facet Malapelle, Umberto
Pallante, Pierlorenzo
author_sort Malapelle, Umberto
collection PubMed
description
format Online
Article
Text
id pubmed-5439169
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54391692017-06-06 Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs Malapelle, Umberto Pallante, Pierlorenzo Front Med (Lausanne) Medicine Frontiers Media S.A. 2017-05-22 /pmc/articles/PMC5439169/ /pubmed/28589123 http://dx.doi.org/10.3389/fmed.2017.00063 Text en Copyright © 2017 Malapelle and Pallante. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Malapelle, Umberto
Pallante, Pierlorenzo
Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_full Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_fullStr Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_full_unstemmed Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_short Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
title_sort editorial: second line treatment of non-small cell lung cancer: clinical, pathological and molecular aspects of novel promising drugs
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439169/
https://www.ncbi.nlm.nih.gov/pubmed/28589123
http://dx.doi.org/10.3389/fmed.2017.00063
work_keys_str_mv AT malapelleumberto editorialsecondlinetreatmentofnonsmallcelllungcancerclinicalpathologicalandmolecularaspectsofnovelpromisingdrugs
AT pallantepierlorenzo editorialsecondlinetreatmentofnonsmallcelllungcancerclinicalpathologicalandmolecularaspectsofnovelpromisingdrugs

Ejemplares similares